Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cells,NVSI-06-08) and Inactivated COVID-19 Vaccine (Vero Cells) in Population Aged 18 Years and Above

Clinical trial NCT05069129 · UNKNOWN

Trial details

NCT number: NCT05069129
Sponsor: National Vaccine and Serum Institute, China
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

COVID-19 Pneumonia Coronavirus Infections

Start date: 2021-10-14
Primary completion: 2023-12-01
Enrollment: 1848

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.